Automatic Web Traffic Generator

CBAHI hosts phase 2 of medical coding program

The Central Board for Accreditation of Healthcare Institutions (CBAHI) recently organized in Riyadh the second phase of its training program specifically designed for qualifying certified medical ... read more

EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress

YUTIQ received a preliminary recommendation from the Centers for Medicare & Medicaid Services (CMS) for a specific J-code through the Healthcare Common Procedure Coding System ... Company's sampling ... read more

Clearside Biomedical, Inc. (CLSD) CEO Daniel White on Q4 2018 Results - Earnings Call Transcript

I would now like to introduce your host ... programs including one-time costs related to closing down the two Phase 3 retinal vein occlusion clinical studies last year. General and administrative ... read more

3-Dimensional characterization of cortical bone microdamage following placement of orthodontic microimplants using Optical Coherence Tomography

Even though, previous studies showed occurrence of microdamage in the cortical bone, they were mainly 2-dimension studies or studies that were invasive to the host. In the present ... in dentistry in ... read more

Watch for New Remittance Advice 'Remark Codes' Related to E-Prescribing

27 that it will host a national provider call on two topics: the PQRS and the e-prescribing incentive program. The call is set for Oct. 18 from 1:30-3 p.m. EDT and will target physicians and medical ... read more

Six Observations About The Healthcare Market From HIMSS 2017

Every year the Healthcare Information and Management Systems Society (HIMSS) hosts one ... with value-based programs too, but the emphasis was dramatic on technological strategies for fee-for-service ... read more

EA Awards Three RNA-Seq Research Grants

DURHAM, NC--(Marketwire -08/16/12)- EA, a Quintiles company, awarded RNA-Seq grants to researchers at Brigham & Women's Hospital, Washington University in St. Louis, and Erasmus Medical College ... read more

Nightstar Reports Positive Proof of Concept Data from Dose Escalation Study in XIRIUS Trial for NSR-RPGR in XLRP Patients

As we move forward with the expansion study, we look forward to continuing to execute our clinical programs and sharing additional data on our XLRP program at future medical meetings.” XIRIUS is a ... read more

What Are the Benefits of Clinical Documentation Improvement (CDI)?

Changing federal initiatives and evolving technologies involving artificial intelligence (AI) will also help support successful CDI programs that ensure patient care remains a top priority. A 2016 ... read more

Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2018 Financial Results

Research and development expenses were $53.1 million and $51.2 million for the years ... the full results from the pivotal Phase 3 trial, which served as the basis of ZILRETTA's approval. Flexion’s ... read more

Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Baker on Q3 2018 Results - Earnings Call Transcript

At this time, I would like to turn the call over to your host, Melissa Downs ... and our confidence in the program, we are evaluating ways to accelerate the compound’s development. In addition to ... read more